ArticleInfection and drug resistance2022
Fatal Rickettsia Japonica Infection Complicating Disseminated Intravascular Coagulation in Yichang, China.
Article in Infection and drug resistance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.
- Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4-trauma, burn, obstetrics, acute pancreatitis/liver failure, and others.International journal of hematology · 2025Guideline
- Japanese Spotted Fever Complicated with Cholecystitis: A Case Report.Surgical case reports · 2026Article
- Case Report: Effective use of omadacycline in Japanese spotted fever.Frontiers in medicine · 2026Article
- Analysis of the Microbial Community Structure ofAnimals : an open access journal from MDPI · 2025Article
- Projecting the potential distribution ofFrontiers in public health · 2025Article
- Article
- Sporadic Human Infections WithTransboundary and emerging diseases · 2025Observational
- Usefulness of next-generation sequencing for laboratory diagnosis of rickettsiosis.PLoS neglected tropical diseases · 2024Article
- Whole genome sequence and comparative genomic analysis of novel Rickettsia koreansis strain CNH17-7 isolated from human.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024Article
- Diagnosing and reintegrating traceability of infectious diseases via metagenomic next-generation sequencing: Study of a severe case ofInfectious medicine · 2024Article
- Survey ofFrontiers in cellular and infection microbiology · 2024Article
- AtypicalInfection and drug resistance · 2024Article
- A Case of Critical Japanese Spotted Fever in Zhejiang, China.Infection and drug resistance · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Severe complications may cause a fatal or disabling outcome in patients with Methods: We identified 11 patients with only Results: Most patients realized that they had symptoms about one or two days after being bitten. Fever (91%), pulmonary effusion (91%), rash or erythema (100%), abnormal urine (100%), neutropenia (100%), lymphopenia (100%), and thrombocytopenia (100%) were the most common clinical signs. Six severely ill patients were admitted to the intensive care unit and five had mild symptoms. Systemic manifestations such as vomiting (83%), neurological manifestations (100%), and disseminated intravascular coagulation (100%) were more frequently observed in the severe cases, 33.3% of whom developed purpura fulminans requiring amputation or skin graft, and 16.6% died two days after admission. Some patients experienced sequelae. Conclusion: Our study found that patients with critical
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.